HomeNews EventsEventsWorkshop: Conducting Economic Evaluation Using Person-Level Data

Workshop: Conducting Economic Evaluation Using Person-Level Data

Date Of Event: 
Wednesday, July 24, 2019

Organised by Health Intervention and Policy Evaluation Research (HIPER) & Singapore Population Health Improvement Centre (SPHERiC)

Health Intervention Economic Evaluation

In an environment with constrained resources, understanding the value for money of a health intervention (e.g., medication, medical device) could support the process for funding and resource allocation decisions.Several analytical approaches and data sources can be used to assess the ‘value for money’ of health interventions. Although aggregate data are often used to populate decision analytic models to show the value for money of the intervention of interest, they remove variability within groups and rely on certain assumptions.

In today’s context, with the emergence of real-world evidence, person-level data (such as those obtained from administrative databases, clinical trials, or observational studies) are becoming more accessible. This workshop will introduce how we could use person-level data to conduct an economic evaluation of a health intervention. Regression techniques can be applied to a health economics analysis and used to estimate incremental cost-effectiveness ratio and incremental net benefit. The use of regression analysis is attractive for a number of reasons such as the fact that it allows the adjustment of potential confounders and the investigation of whether the value for money of health interventions varies across population subgroups. This workshop will illustrate the concepts and potential roles of person-level data in health technology assessment.




Workshop Details:

24 & 25 July 2019 (Wednesday & Thursday)

Day 1: 9.00am - 5.00pm
Day 2: 9.00am - 5.00pm

Computer Lab 2 (Level 8)
Tahir Foundation Building (MD1), 12 Science Drive 2, Singapore 117549.



  • To understand how to conduct cost-effectiveness analysis using person-level data and regression technique

  • To explore techniques for characterizing the uncertainty in person-level cost-effectiveness analysis

  • To explain the results of person-level cost-effectiveness analyses in a way that improves the chances of them being understood



The workshop will introduce a method for estimation and uncertainty of cost-effectiveness statistics using person-level data. The focus is on techniques to create and explain economic information from person-level data (e.g., from clinical trials, observational studies, or administrative databases).


Who Should Attend?

  • Clinician

  • Researchers

  • Anyone interested in economic evaluation using person-level data



  • Basic understanding knowledge of regression and economic evaluation (e.g., cost-effectiveness analysis)

  • Basic experience with STATA


Teaching Faculty:

Dr Wanrudee Isaranuwatchai

Dr Wanrudee Isaranuwatchai

Dr Wee Hwee Lin

Dr Wee Hwee Lin

Dr Wanrudee Isaranuwatchai is a Senior Researcher at the Health Intervention and Technology Assessment Program (HITAP) (a part of the Ministry of Public Health) in Bangkok, Thailand, and a Research Scientist at the Centre for Excellence in Economic Analysis Research of St. Michael’s Hospital, and at the Canadian Centre for Applied Research in Cancer Control in Canada. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto. Her research focuses on how to apply economic evaluation in the real world setting as well as how to advance methods in economic evaluation. She has experience conducting economic evaluations using person-level data and decision modeling. She has collaborated with researchers and decision-makers in various areas to help communicate the value of health initiatives using economic evidence. Dr. Isaranuwatchai is dedicated to promote the use of evidence in healthcare decision making. Read more

Dr Wee is a joint Assistant Professor in the Saw Swee Hock School of Public Health and Department of Pharmacy, Faculty of Science at the National University of Singapore. She has served as an elected member of the Board of Directors of ISOQOL and was also an associate editor of a BMC journal on health-related quality of life. She is currently President of the International Society for Pharmacoeconomics and Outcomes Research Singapore Regional Chapter, and her current work involves understanding patient preferences for high cost treatments, public preferences for preemptive pharmacogenetic testing and factors associated with well-being among Singaporeans.      Read more




Course Fees*:

  • Student**/Staffs of NUS Saw Swee Hock School of Public Health/Low-and-Middle Income Countries: S$350

  • NUHS Staff/Members of HTAsiaLink and iDSI: S$600

  • Non-Student: S$900

*Inclusive of GST. Non refundable.

**students to provide letter of support from the Department/School that you are a current student



Register by 15 June 2019

For more details, contact: Ms TOH Kai Yee, (65) 6516 5782 or ephtky@nus.edu.sg


Saw Swee Hock School of Public Health
Tahir Foundation Building
National University of Singapore
12 Science Drive 2
Singapore 117549
For all visitors, kindly proceed to Level 10 Reception Area at MD1
Telephone: (65) 6516 4988
Fascimile: (65) 6779 1489

Connect With Us:     

© National University of Singapore. All Rights Reserved.
Legal   Branding guidelines